These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28586017)

  • 61. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.
    Gao K; Liang Q; Zhao ZH; Li YF; Wang SF
    World J Gastroenterol; 2016 Mar; 22(10):2971-80. PubMed ID: 26973393
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
    Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
    Sun WJ; Huang H; He B; Hu DH; Li PH; Yu YJ; Zhou XH; Lv Z; Zhou L; Hu TY; Yao ZC; Lu MD; Shen X; Zheng ZQ
    Biochem Pharmacol; 2017 Mar; 127():90-100. PubMed ID: 28012958
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induction of G2/M phase arrest and apoptosis of human leukemia cells by potent antitumor triazoloacridinone C-1305.
    Augustin E; Moś-Rompa A; Skwarska A; Witkowski JM; Konopa J
    Biochem Pharmacol; 2006 Dec; 72(12):1668-79. PubMed ID: 16970926
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
    Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
    Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis and antiproliferative activity of novel methylselenocarbamates.
    Romano B; Font M; Encío I; Palop JA; Sanmartín C
    Eur J Med Chem; 2014 Aug; 83():674-84. PubMed ID: 25014639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and evaluation of 2-carboxy indole derivatives as potent and selective anti-leukemic agents.
    Cury NM; Capitão RM; Almeida RDCB; Artico LL; Corrêa JR; Simão Dos Santos EF; Yunes JA; Correia CRD
    Eur J Med Chem; 2019 Nov; 181():111570. PubMed ID: 31408809
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Leukemia Cell Cycle Chemical Profiling Identifies the G2-Phase Leukemia Specific Inhibitor Leusin-1.
    Xia X; Lo YC; Gholkar AA; Senese S; Ong JY; Velasquez EF; Damoiseaux R; Torres JZ
    ACS Chem Biol; 2019 May; 14(5):994-1001. PubMed ID: 31046221
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthetic 1,2,4-triazole-3-carboxamides Induce Cell Cycle Arrest and Apoptosis in Leukemia Cells.
    Ekaterina Z; Daria S; Lyubov G; Ekaterina M; Varvara M; Diana G; Andrey M; Ekaterina L
    Curr Pharm Des; 2023; 29(43):3478-3487. PubMed ID: 38083885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Organic phenyl arsonic acid compounds with potent antileukemic activity.
    Liu XP; Narla RK; Uckun FM
    Bioorg Med Chem Lett; 2003 Feb; 13(3):581-3. PubMed ID: 12565976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia.
    Chang Y; Keramatnia F; Ghate PS; Nishiguchi G; Gao Q; Iacobucci I; Yang L; Chepyala D; Mishra A; High AA; Goto H; Akahane K; Peng J; Yang JJ; Fischer M; Rankovic Z; Mullighan CG
    Blood; 2023 Aug; 142(7):629-642. PubMed ID: 37172201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Classification of Congeneric and QSAR of Homologous Antileukemic
    Castellano G; León A; Torrens F
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466352
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of combinations of antileukemic agents on an acute lymphocytic leukemia of mice.
    LAW LW
    Cancer Res; 1952 Dec; 12(12):871-8. PubMed ID: 13009674
    [No Abstract]   [Full Text] [Related]  

  • 75. Correction: KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
    You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
    PLoS One; 2019; 14(11):e0225087. PubMed ID: 31693709
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The mechanism of action of antileukemic drugs.
    BURCHENAL JH
    Rev Hematol; 1955; 10(2):485-6. PubMed ID: 13255446
    [No Abstract]   [Full Text] [Related]  

  • 77. Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies.
    Dallavalasa S; Tulimilli SV; Bettada VG; Karnik M; Uthaiah CA; Anantharaju PG; Nataraj SM; Ramashetty R; Sukocheva OA; Tse E; Salimath PV; Madhunapantula SV
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.
    Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086
    [TBL] [Abstract][Full Text] [Related]  

  • 79. KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
    Liu Y; Shin DY; Oh S; Kim S; Koh Y; Kim I
    Oncol Rep; 2017 Jul; 38(1):481-487. PubMed ID: 28586017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
    Yoon JS; Hwang DW; Kim ES; Kim JS; Kim S; Chung HJ; Lee SK; Yi JH; Uhm J; Won YW; Park BB; Choi JH; Lee YY
    Invest New Drugs; 2016 Feb; 34(1):1-14. PubMed ID: 26581399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.